Ranjeet Prasad Dash

1.6k total citations
52 papers, 1.2k citations indexed

About

Ranjeet Prasad Dash is a scholar working on Molecular Biology, Pharmacology and Pharmacology. According to data from OpenAlex, Ranjeet Prasad Dash has authored 52 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 12 papers in Pharmacology and 12 papers in Pharmacology. Recurrent topics in Ranjeet Prasad Dash's work include Pharmacogenetics and Drug Metabolism (7 papers), Sphingolipid Metabolism and Signaling (5 papers) and Analytical Methods in Pharmaceuticals (5 papers). Ranjeet Prasad Dash is often cited by papers focused on Pharmacogenetics and Drug Metabolism (7 papers), Sphingolipid Metabolism and Signaling (5 papers) and Analytical Methods in Pharmaceuticals (5 papers). Ranjeet Prasad Dash collaborates with scholars based in United States, India and Czechia. Ranjeet Prasad Dash's co-authors include Nuggehally R. Srinivas, R. Jayachandra Babu, Manish Nivsarkar, Rana Rais, Barbara S. Slusher, Manju Misra, Sheetal Anandjiwala, Jenny Lam, Jesse Alt and Lukáš Tenora and has published in prestigious journals such as Journal of Medicinal Chemistry, Science Advances and British Journal of Pharmacology.

In The Last Decade

Ranjeet Prasad Dash

52 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ranjeet Prasad Dash United States 21 441 147 146 138 121 52 1.2k
Gamaleldin I. Harisa Saudi Arabia 23 506 1.1× 116 0.8× 139 1.0× 238 1.7× 90 0.7× 88 1.5k
Chuanlong Guo China 25 627 1.4× 99 0.7× 200 1.4× 133 1.0× 168 1.4× 90 1.7k
Ubonthip Nimmannit Thailand 21 743 1.7× 207 1.4× 162 1.1× 216 1.6× 139 1.1× 39 1.7k
Dhanalekshmi Unnikrishnan Meenakshi India 21 450 1.0× 217 1.5× 47 0.3× 158 1.1× 103 0.9× 45 1.3k
Yan Tian China 21 629 1.4× 136 0.9× 147 1.0× 237 1.7× 99 0.8× 62 1.4k
Ningning He China 24 936 2.1× 187 1.3× 96 0.7× 86 0.6× 125 1.0× 89 1.7k
Miwon Son South Korea 26 448 1.0× 105 0.7× 127 0.9× 175 1.3× 56 0.5× 78 1.7k
Yanna Cheng China 29 933 2.1× 218 1.5× 266 1.8× 238 1.7× 153 1.3× 66 2.0k
Ling Tao China 23 541 1.2× 139 0.9× 78 0.5× 61 0.4× 64 0.5× 81 1.4k
Usama A. Fahmy Saudi Arabia 24 459 1.0× 98 0.7× 130 0.9× 542 3.9× 106 0.9× 84 1.7k

Countries citing papers authored by Ranjeet Prasad Dash

Since Specialization
Citations

This map shows the geographic impact of Ranjeet Prasad Dash's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ranjeet Prasad Dash with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ranjeet Prasad Dash more than expected).

Fields of papers citing papers by Ranjeet Prasad Dash

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ranjeet Prasad Dash. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ranjeet Prasad Dash. The network helps show where Ranjeet Prasad Dash may publish in the future.

Co-authorship network of co-authors of Ranjeet Prasad Dash

This figure shows the co-authorship network connecting the top 25 collaborators of Ranjeet Prasad Dash. A scholar is included among the top collaborators of Ranjeet Prasad Dash based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ranjeet Prasad Dash. Ranjeet Prasad Dash is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nedelcovych, Michael T., Ranjeet Prasad Dash, Ying Wu, et al.. (2025). JHU-2545 preferentially shields salivary glands and kidneys during PSMA-targeted imaging. European Journal of Nuclear Medicine and Molecular Imaging. 52(5). 1631–1641. 2 indexed citations
2.
Rais, Rana, Kathryn M. Lemberg, Lukáš Tenora, et al.. (2022). Discovery of DRP-104, a tumor-targeted metabolic inhibitor prodrug. Science Advances. 8(46). eabq5925–eabq5925. 77 indexed citations
3.
Alt, Jesse, Kathryn M. Lemberg, Arindom Pal, et al.. (2021). Glutamine Antagonist GA-607 Causes a Dramatic Accumulation of FGAR which can be used to Monitor Target Engagement. Current Drug Metabolism. 22(9). 735–745. 3 indexed citations
4.
Nedelcovych, Michael T., Xiaolei Zhu, Jennifer Kelschenbach, et al.. (2021). Correction to: Glutamine Antagonist JHU083 Normalizes Aberrant Glutamate Production and Cognitive Deficits in the EcoHIV Murine Model of HIV-Associated Neurocognitive Disorders. Journal of Neuroimmune Pharmacology. 16(3). 693–693. 1 indexed citations
5.
Kurakula, Mallesh, Li Chen, Amit K. Tiwari, et al.. (2021). Recent Advances in Lipid-Based Nanovesicular Delivery Systems for Melanoma Therapy. Critical Reviews in Therapeutic Drug Carrier Systems. 38(4). 1–38. 9 indexed citations
6.
7.
Dash, Ranjeet Prasad, et al.. (2020). Protein Binding and Stability of Drug Candidates: The Achilles’ Heel in In Vitro Potency Assays. European Journal of Drug Metabolism and Pharmacokinetics. 45(4). 427–432. 1 indexed citations
8.
Lemberg, Kathryn M., Liang Zhao, Ying Wu, et al.. (2019). The Novel Glutamine Antagonist Prodrug JHU395 Has Antitumor Activity in Malignant Peripheral Nerve Sheath Tumor. Molecular Cancer Therapeutics. 19(2). 397–408. 16 indexed citations
9.
Alrbyawi, Hamad, Ishwor Poudel, Ranjeet Prasad Dash, et al.. (2019). Role of Ceramides in Drug Delivery. AAPS PharmSciTech. 20(7). 287–287. 9 indexed citations
10.
Nedelcovych, Michael T., Xiaolei Zhu, Jennifer Kelschenbach, et al.. (2019). Glutamine Antagonist JHU083 Normalizes Aberrant Glutamate Production and Cognitive Deficits in the EcoHIV Murine Model of HIV-Associated Neurocognitive Disorders. Journal of Neuroimmune Pharmacology. 14(3). 391–400. 30 indexed citations
11.
Hin, Niyada, Ajit G. Thomas, Ranjeet Prasad Dash, et al.. (2019). Neutral sphingomyelinase 2 inhibitors based on the 4-(1H-imidazol-2-yl)-2,6-dialkoxyphenol scaffold. European Journal of Medicinal Chemistry. 170. 276–289. 11 indexed citations
12.
Dash, Ranjeet Prasad, R. Jayachandra Babu, & Nuggehally R. Srinivas. (2018). Non-alcoholic Steatohepatitis (NASH) Drug Discovery – Building a Consensus on ADME Screening Tools and Clinical Pharmacology Strategies to Aid Candidate Development. Journal of Pharmacy & Pharmaceutical Sciences. 21(1). 481–495. 4 indexed citations
13.
Dash, Ranjeet Prasad, Nuggehally R. Srinivas, & Rana Rais. (2017). A review of bioanalytical quantitative methods for selected sphingosine 1‐phosphate receptor modulators. Biomedical Chromatography. 32(1). 5 indexed citations
14.
Dash, Ranjeet Prasad, R. Jayachandra Babu, & Nuggehally R. Srinivas. (2017). Review of the pharmacokinetics of dalbavancin, a recently approved lipoglycopeptide antibiotic. Infectious Diseases. 49(7). 483–492. 29 indexed citations
15.
Dash, Ranjeet Prasad, et al.. (2017). Implication of Formulation Strategies on the Bioavailability of Selected Plant-Derived Hepatoprotectants. Critical Reviews in Therapeutic Drug Carrier Systems. 34(6). 489–526. 5 indexed citations
16.
Dash, Ranjeet Prasad, R. Jayachandra Babu, & Nuggehally R. Srinivas. (2017). Therapeutic Potential and Utility of Elacridar with Respect to P-glycoprotein Inhibition: An Insight from the Published In Vitro, Preclinical and Clinical Studies. European Journal of Drug Metabolism and Pharmacokinetics. 42(6). 915–933. 67 indexed citations
17.
18.
Sagar, Sneha R., et al.. (2015). Design, synthesis and biological evaluation of novel pyrazolo-pyrimidinones as DPP-IV inhibitors in diabetes. Bioorganic & Medicinal Chemistry Letters. 25(20). 4428–4433. 34 indexed citations
19.
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gamaleldin I. Harisa Breakdown of academic impact, for papers by Chuanlong Guo Breakdown of academic impact, for papers by Ubonthip Nimmannit Breakdown of academic impact, for papers by Dhanalekshmi Unnikrishnan Meenakshi Breakdown of academic impact, for papers by Yan Tian Breakdown of academic impact, for papers by Ningning He Breakdown of academic impact, for papers by Miwon Son Breakdown of academic impact, for papers by Yanna Cheng Breakdown of academic impact, for papers by Ling Tao Breakdown of academic impact, for papers by Usama A. Fahmy
Rankless by CCL
2026